Functional implications of aging-related lncRNAs for predicting prognosis and immune status in glioma patients
preprint
OA: closed
Abstract
Glioma, is the most prevalent intracranial tumor with high recurrence and mortality rate. Long noncoding RNAs (lncRNAs) play a critical role in the occurrence and progression of tumors as well as in aging regulation. Our study aimed to establish a new glioma prognosis model by integrating aging-related lncRNAs expression profiles and clinical parameters in glioma patients from the Chinese Glioma Genome Atlas (CGGA) and the Cancer Genome Atlas (TCGA) datasets. The Pearson correlation analysis (|R|> 0.6, P<0.001) was performed to explore the aging-related lncRNAs, and univariate cox tregresion and least absolute shrinkage and selection operator (LASSO) regression were used to screening prognostic signature in glioma patients. Based on the fifteen lncRNAs, we can divide glioma patients into three subtypes, and developed a prognostic model. Kaplan-Meier survival curve analysis showed that low-risk patients had longer survival time than high-risk group. Principal component analysis indicated that aging-related lncRNAs signature had a clear distinction between high- and low-risk groups. We also found that fifteen target lncRNAs were closely correlated with 119 genes by establishing a co-expression network. In addition, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis displayed different function and pathways enrichment in high-and low-risk groups. The different missense mutations were observed in two groups, and the most frequent variant types were single nucleotide polymorphism (SNP). This study demonstrated that the novel aging-related lncRNAs signature had an important prognosis prediction and may contribute to individual treatment for glioma.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (30)
- doi:10.1016/j.canlet.2016.10.009 via crossref
- doi:10.1007/s11912-019-0783-5 via crossref
- doi:10.1093/neuonc/nov164 via crossref
- doi:10.1007/s00401-018-1825-z via crossref
- doi:10.1038/nrg3606 via crossref
- doi:10.1038/nature10887 via crossref
- doi:10.1186/s13046-018-0875-3 via crossref
- doi:10.1038/onc.2015.340 via crossref
- doi:10.1002/jcp.28765 via crossref
- doi:10.1016/j.canlet.2018.01.041 via crossref
- doi:10.1038/s41467-020-14802-2 via crossref
- doi:10.1038/nm1784 via crossref
- doi:10.1038/s41590-018-0207-y via crossref
- doi:10.1038/nrd.2017.116 via crossref
- doi:10.1111/nan.12689 via crossref
- doi:10.1038/nm.3981 via crossref
- doi:10.3389/fonc.2019.01348 via crossref
- doi:10.1002/jmv.25673 via crossref
- doi:10.1016/j.arr.2017.04.004 via crossref
- doi:10.1111/nan.12689 via crossref
- doi:10.1016/j.it.2015.02.009 via crossref
- doi:10.1158/1078-0432.ccr-19-3874 via crossref
- doi:10.1016/j.celrep.2017.12.039 via crossref
- doi:10.1158/0008-5472.can-16-1615 via crossref
- doi:10.15252/embj.2019102190 via crossref
- doi:10.1038/s41419-020-03346-4 via crossref
- doi:10.1016/j.omtn.2020.05.003 via crossref
- doi:10.1111/jcmm.15488 via crossref
- doi:10.1186/s12935-021-01993-x via crossref
- doi:10.1038/s41588-020-00727-5 via crossref
Source provenance
- crossref
- last seen: 2026-07-12T06:45:56.598701+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-30T08:32:49.343555+00:00